arasertaconazole
Small moleculeexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2010 (NCT01144286)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Cytochrome P450 14alpha-demethylaseINHIBITOR
cyp51 inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
Clc1ccc([C@H](Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1- Mol. weight
- 437.78 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1410877 ↗
Also known as
- arasertaconazole
- arasertaconazole
- arasertaconazole nitrate
- arasertaconazole nitrate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01144286 | Phase 2 | Jun 1, 2010 | Ferrer Internacional S.A. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ferrer Internacional S.A. | For profit | 1 | 1 | 1 | 2010 |
1 organizations
Page 1 / 1